ATG:Biosynthetics will be presenting their technology at the 13th German Peptide Symposium
Date:
Monday, February 13, 2017
From 20-23 March 2017, ATG:Biosynthetics will be at the 13th German Peptide Symposium at the University of Erlangen-Nürnberg.
ATG
Maximising the Impact of KET Biotechnology: the MycoSynVac experience
Date:
Wednesday, November 16, 2016
Professor Alain Blanchard from INRA Bourdeaux and Dr. Hubert Bernauer, CEO of the SME ATG:biosynthetics GmbH, participated as invited speakers in this workshop which was organised by the Directorate-General for Research and Innovation of the European Commission.